Supporting the local manufacture of diagnostics

CASE STUDIES & NEWS ARTICLES

Packets of the IT-Leish rapid diagnostic test (RDT) for visceral leishmaniasis are displayed against a gradient background transitioning from teal to purple. Each white packet is clearly labeled with identification details including "IT LEISH", lot numbers, and expiration dates, along with the IVD (in vitro diagnostic) symbol, emphasizing their use in medical diagnostics. The packets are partially overlapped, focusing on their essential information and sterile packaging.
By Dr Sophie Owen

GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, today announced the launch of IT LEISH a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The…
COVI-GO-1920w
By Dr Andrew Wheeler

COVID-19 Rapid Antigen Self-Test, COVI-Go™, receives FDA Emergency Use Authorization for home use

Mologic Inc., the US subsidiary of  Global Access Diagnostics (GADx), a leading developer of lateral flow and rapid diagnostic technologies, products and services, announced today that its proprietary COVI-Go™…
Close-up view of a professional laboratory microscope with multiple objective lenses, focused on the lenses with a blurred laboratory background.
By Dr Sophie Owen

GADx acquires manufacturing rights for IT LEISH rapid diagnostic test from Bio-Rad Laboratories

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced it has acquired the manufacturing rights for the IT LEISH rapid…

GET IN TOUCH

For sales inquiries please contact sales@globalaccessdx.com
For technical support please contact technicalsupport@globalaccessdx.com

Frequent testing is invaluable and so it is vital to find ways to drive down the cost of kits and increase production levels. As a social enterprise, GADx can transform this process because it ‘breaks the link’ of ‘having to make profit for shareholders’.

Paul Davis
Co-founder of Mologic and pioneer of lateral flow diagnostics.